SARS-CoV-2 (COVID-19) Spike S1 Protein (RBD), lyophilized formulation Size:1mg reaction time

reaction time

nutritional status and inflammatory conditions

blueTEV has been optimized by site directed mutagenesis to prevent autocatalytic cleavage

The G4 EA H1N1 viruses have the ability to grow well in human lung cells and show efficient infectivity and aerosol transmission in ferrets

Citation Date Citation Title Citation Authors Citation Abstract Citation DOI 18 May 2021 SARS-CoV-2 infects lung epithelial cells and induces senescence and an inflammatory response in patients with severe COVID-19 Konstantinos Evangelou

SARS-CoV-2 (COVID-19) Spike S1 Protein (RBD), lyophilized formulation Size:1mg reaction timeRecombinant protein of the receptor binding domain (RBD) of SARS CoV 2 (COVID 19) Spike S1 from Wuhan pneumonia virus with C terminal His Tag, lyophilized formulation. Overview Product Name: SARS CoV 2 (COVID 19) Spike S1 Protein (RBD), lyophilized formulation Catalog No.: P2020 021 RefSeq Links: NC_045512. 2; MN908947. 3; YP_009724390. 1; QHD43416. 1; GeneID: 43740568; UniProt: P0DTC2 Synonyms: SARS CoV 2; coronavirus; SARS CoV 2 spike RBD; SARS CoV